356 related articles for article (PubMed ID: 32664415)
21. Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology.
Vascotto C; Lirussi L; Poletto M; Tiribelli M; Damiani D; Fabbro D; Damante G; Demple B; Colombo E; Tell G
Oncogene; 2014 May; 33(22):2876-87. PubMed ID: 23831574
[TBL] [Abstract][Full Text] [Related]
22. Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias.
Falini B; Nicoletti I; Bolli N; Martelli MP; Liso A; Gorello P; Mandelli F; Mecucci C; Martelli MF
Haematologica; 2007 Apr; 92(4):519-32. PubMed ID: 17488663
[TBL] [Abstract][Full Text] [Related]
23. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
[TBL] [Abstract][Full Text] [Related]
24. Structure of nucleophosmin DNA-binding domain and analysis of its complex with a G-quadruplex sequence from the c-MYC promoter.
Gallo A; Lo Sterzo C; Mori M; Di Matteo A; Bertini I; Banci L; Brunori M; Federici L
J Biol Chem; 2012 Aug; 287(32):26539-48. PubMed ID: 22707729
[TBL] [Abstract][Full Text] [Related]
25. Nucleophosmin C-terminal leukemia-associated domain interacts with G-rich quadruplex forming DNA.
Federici L; Arcovito A; Scaglione GL; Scaloni F; Lo Sterzo C; Di Matteo A; Falini B; Giardina B; Brunori M
J Biol Chem; 2010 Nov; 285(48):37138-49. PubMed ID: 20858903
[TBL] [Abstract][Full Text] [Related]
26. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
[TBL] [Abstract][Full Text] [Related]
27. EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML.
Skayneh H; Jishi B; Hleihel R; Hamie M; El Hajj R; Deleuze-Masquefa C; Bonnet PA; El Sabban M; El Hajj H
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408798
[TBL] [Abstract][Full Text] [Related]
28. Nucleophosmin 1 Mutations in Acute Myeloid Leukemia.
Zarka J; Short NJ; Kanagal-Shamanna R; Issa GC
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32545659
[TBL] [Abstract][Full Text] [Related]
29. A Curious Novel Combination of
Venanzi A; Rossi R; Martino G; Annibali O; Avvisati G; Mameli MG; Sportoletti P; Tiacci E; Falini B; Martelli MP
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573408
[No Abstract] [Full Text] [Related]
30. Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1.
Balusu R; Fiskus W; Rao R; Chong DG; Nalluri S; Mudunuru U; Ma H; Chen L; Venkannagari S; Ha K; Abhyankar S; Williams C; McGuirk J; Khoury HJ; Ustun C; Bhalla KN
Blood; 2011 Sep; 118(11):3096-106. PubMed ID: 21719597
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel nucleophosmin-interaction motif in the tumor suppressor p14arf.
Luchinat E; Chiarella S; Franceschini M; Di Matteo A; Brunori M; Banci L; Federici L
FEBS J; 2018 Mar; 285(5):832-847. PubMed ID: 29283500
[TBL] [Abstract][Full Text] [Related]
32. Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (
Chin L; Wong CYG; Gill H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834572
[TBL] [Abstract][Full Text] [Related]
33. When the good go bad: Mutant NPM1 in acute myeloid leukemia.
Kunchala P; Kuravi S; Jensen R; McGuirk J; Balusu R
Blood Rev; 2018 May; 32(3):167-183. PubMed ID: 29157973
[TBL] [Abstract][Full Text] [Related]
34. Germline NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenita.
Nachmani D; Bothmer AH; Grisendi S; Mele A; Bothmer D; Lee JD; Monteleone E; Cheng K; Zhang Y; Bester AC; Guzzetti A; Mitchell CA; Mendez LM; Pozdnyakova O; Sportoletti P; Martelli MP; Vulliamy TJ; Safra M; Schwartz S; Luzzatto L; Bluteau O; Soulier J; Darnell RB; Falini B; Dokal I; Ito K; Clohessy JG; Pandolfi PP
Nat Genet; 2019 Oct; 51(10):1518-1529. PubMed ID: 31570891
[TBL] [Abstract][Full Text] [Related]
35. [Research on NPM1 gene mutations in acute myeloid leukemia].
Chen HY; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):258-62. PubMed ID: 23484732
[TBL] [Abstract][Full Text] [Related]
36. ZNF692 regulates nucleolar morphology by interacting with NPM1 and modifying its self-assembly properties.
Brown IN; Levario A; Jiang C; Stachera W; Rodriguez E; Hao YH; Woodruff JB; Lafita-Navarro MC; Conacci-Sorrell M
J Biol Chem; 2024 Mar; 300(3):105773. PubMed ID: 38382671
[TBL] [Abstract][Full Text] [Related]
37. Mutant NPM1 Hijacks Transcriptional Hubs to Maintain Pathogenic Gene Programs in Acute Myeloid Leukemia.
Wang XQD; Fan D; Han Q; Liu Y; Miao H; Wang X; Li Q; Chen D; Gore H; Himadewi P; Pfeifer GP; Cierpicki T; Grembecka J; Su J; Chong S; Wan L; Zhang X
Cancer Discov; 2023 Mar; 13(3):724-745. PubMed ID: 36455589
[TBL] [Abstract][Full Text] [Related]
38. NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling.
Lindström MS
Biochem Res Int; 2011; 2011():195209. PubMed ID: 21152184
[TBL] [Abstract][Full Text] [Related]
39. Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins displaying R-rich linear motifs and rRNA.
Mitrea DM; Cika JA; Guy CS; Ban D; Banerjee PR; Stanley CB; Nourse A; Deniz AA; Kriwacki RW
Elife; 2016 Feb; 5():. PubMed ID: 26836305
[TBL] [Abstract][Full Text] [Related]
40. Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates.
Gu X; Ebrahem Q; Mahfouz RZ; Hasipek M; Enane F; Radivoyevitch T; Rapin N; Przychodzen B; Hu Z; Balusu R; Cotta CV; Wald D; Argueta C; Landesman Y; Martelli MP; Falini B; Carraway H; Porse BT; Maciejewski J; Jha BK; Saunthararajah Y
J Clin Invest; 2018 Oct; 128(10):4260-4279. PubMed ID: 30015632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
